FDA Consent Decree’s Impact Is Limited, GSK Says
This article was originally published in The Pink Sheet Daily
You may also be interested in...
Ripping The Bandage Off: GSK Resolves Suits On Many Products For $2.3 Bil.
GlaxoSmithKline's decision to resolve its most onerous litigation in one fell swoop put it among the largest payouts by a pharma company
Ripping The Bandage Off: GSK Resolves Suits On Many Products For $2.3 Bil.
GlaxoSmithKline's decision to resolve its most onerous litigation in one fell swoop put it among the largest payouts by a pharma company
Schering Suit Triggers 30-Month Stay Of Action On Clarinex ANDAs
More than a dozen generic drug makers face patent infringement suits.